unknown
Stage
1
Investors
About
Develops a drug delivery platform that encapsulates therapeutic molecules into a patient’s own red blood cells (erythrocytes) to use them as vehicles for sustained or targeted delivery of drugs.
Explore EryDel's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.